Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects

por Afifi, Ahmed M, El-Husseiny, Ahmed M, Tabashy, Reda H, Khalil, Mohamed A, El-Houseini, Motawa E
Publicado 2019

Serological Biomarkers of Hepatocellular Carcinoma in Egyptian Patients

por El-Tayeh, Sarmad F., Hussein, Tarek D., El-Houseini, Motawa E., Amer, Mahmoud A., El-Sherbini, Mamdooh, Elshemey, Wael M.
Publicado 2012

The potential immuno-stimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study

por kotb, Raghda R., Afifi, Ahmed M., EL-Houseini, Motawa E., Ezz-Elarab, Mohamed, Basalious, Emad B., Omran, Mervat M., Abdellateif, Mona S.
Publicado 2023

Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients

por Abdelaziz, Heba E., El-Guendy, Nadia, Radwan, Enas M, Sharawi, Sabry K, El Houseini, Motawa E, Abdel-Wahab, Abdel-Hady A
Publicado 2022

Biological and molecular studies on specific immune cells treated with checkpoint inhibitors for the thera-personal approach of breast cancer patients (ex-vivo study)

por EL-HOUSEINI, MOTAWA E., ARAFAT, MOSTAFA S., EL-HUSSEINY, AHMED M., KASEM, ISLAM M., KAMEL, MAHMOUD M., EL-HABASHY, AHMED H., KHAFAGY, MEDHAT M., RADWAN, ENAS M., HELAL, MAHA H., ABDELLATEIF, MONA S.
Publicado 2022